In a 4T1 TNBC mouse cancer model, phenelzine or EPI-111 reduced the mesenchymal, stem-like population more than either anti-PD1 therapy or Abraxane, both of which did not significantly after the mesenchymal, stem-like population (Figures 2F,G). Here, PDCD1 is linked to cancer.